Qsemble Capital Management LP trimmed its stake in Palantir Technologies Inc. (NYSE:PLTR – Free Report) by 87.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,512 shares of the company’s stock after selling 46,456 shares during the period. Qsemble Capital Management LP’s holdings in Palantir Technologies were worth $242,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of the stock. Trust Asset Management LLC bought a new stake in Palantir Technologies in the third quarter valued at $960,000. Private Trust Co. NA grew its position in Palantir Technologies by 14.2% in the third quarter. Private Trust Co. NA now owns 5,903 shares of the company’s stock valued at $220,000 after acquiring an additional 736 shares during the period. Canton Hathaway LLC grew its position in Palantir Technologies by 74.1% in the third quarter. Canton Hathaway LLC now owns 4,700 shares of the company’s stock valued at $175,000 after acquiring an additional 2,000 shares during the period. Truvestments Capital LLC grew its position in Palantir Technologies by 2.4% in the third quarter. Truvestments Capital LLC now owns 12,169 shares of the company’s stock valued at $453,000 after acquiring an additional 291 shares during the period. Finally, Boston Family Office LLC grew its holdings in shares of Palantir Technologies by 48.0% during the third quarter. Boston Family Office LLC now owns 37,000 shares of the company’s stock worth $1,376,000 after purchasing an additional 12,000 shares during the last quarter. 45.65% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
PLTR has been the subject of a number of research reports. Jefferies Financial Group lowered Palantir Technologies from a “hold” rating to an “underperform” rating and set a $28.00 target price for the company. in a research note on Thursday, November 7th. Monness Crespi & Hardt lowered their target price on Palantir Technologies from $20.00 to $18.00 and set a “sell” rating for the company in a research note on Tuesday, August 6th. Bank of America raised their target price on Palantir Technologies from $55.00 to $75.00 and gave the company a “buy” rating in a research note on Monday. Raymond James lowered Palantir Technologies from an “outperform” rating to a “market perform” rating in a research note on Monday, September 23rd. Finally, Wedbush raised their target price on Palantir Technologies from $57.00 to $75.00 and gave the company an “outperform” rating in a research note on Monday. Six research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $35.64.
Palantir Technologies Trading Up 0.5 %
Shares of PLTR opened at $66.05 on Thursday. Palantir Technologies Inc. has a 1 year low of $15.66 and a 1 year high of $67.88. The stock has a market cap of $150.46 billion, a P/E ratio of 330.25 and a beta of 2.70. The stock’s 50-day moving average price is $47.68 and its two-hundred day moving average price is $34.33.
Palantir Technologies (NYSE:PLTR – Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Palantir Technologies had a return on equity of 9.94% and a net margin of 18.01%. The firm had revenue of $725.52 million for the quarter, compared to analysts’ expectations of $705.11 million. During the same quarter last year, the business earned $0.03 earnings per share. The company’s revenue was up 30.0% compared to the same quarter last year. As a group, equities analysts forecast that Palantir Technologies Inc. will post 0.21 EPS for the current year.
Insider Buying and Selling at Palantir Technologies
In related news, Director Alexander D. Moore sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $30.89, for a total transaction of $617,800.00. Following the transaction, the director now directly owns 1,510,630 shares of the company’s stock, valued at approximately $46,663,360.70. The trade was a 1.31 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Lauren Elaina Friedman Stat sold 9,746 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $66.77, for a total value of $650,740.42. Following the completion of the sale, the director now owns 111,644 shares of the company’s stock, valued at $7,454,469.88. This trade represents a 8.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,163,181 shares of company stock worth $1,603,288,758. Corporate insiders own 12.93% of the company’s stock.
Palantir Technologies Company Profile
Palantir Technologies Inc builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform.
Featured Articles
- Five stocks we like better than Palantir Technologies
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Why Invest in High-Yield Dividend Stocks?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Buy Cheap Stocks Step by Step
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Palantir Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palantir Technologies and related companies with MarketBeat.com's FREE daily email newsletter.